Physician profile
William George Schultz
NPI 1730256058
$3,194.63
in general payments reported to CMS, 2019-2025
16 companies · $257 in 2025
The $257 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $27.78 · 2021: $205 · 2022: $187 · 2023: $1,627 · 2024: $486 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,195 · Travel and Lodging: $1,175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,194.93 |
| Travel and Lodging | $1,174.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,680.95 | 2021-2024 | |
| Abbvie INC. | $318.19 | 2023-2025 | Alphagan P, Lumigan |
| Novartis Pharmaceuticals Corporation | $218.44 | 2019-2021 | |
| Allergan, INC. | $168.83 | 2020-2022 | |
| Rxsight INC | $149.96 | 2022-2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $138.69 | 2019-2020 | |
| Sight Sciences, INC. | $119.26 | 2024-2025 | Omni Surgical System |
| Seagen INC. | $88.20 | 2022 | |
| Coopervision INC. | $72.60 | 2019-2025 | Myday Contact Lens |
| Optos, INC. | $63.41 | 2019 | |
| Sun Pharmaceutical Industries INC. | $54.37 | 2024-2025 | |
| Alcon Vision LLC | $35.69 | 2023-2025 | Rocklatan |
| Dompe US, INC. | $30.91 | 2025 | Oxervate |
| Aerie Pharmaceuticals, INC. | $21.73 | 2021 | |
| Horizon Therapeutics Plc | $19.29 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $14.11 | 2025 | Xiidra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.